Application Note CTS Detachable Dynabeads CD3-CD28 Kit

Introduction Nearly two decades ago, Gibco CTS Dynabeads CD3/CD28 technology was used in the first pioneering, clinically approved CAR T cell therapy [1]. The antibody-coated magnetic beads were crucial in the manufacturing process to achieve one-step cell isolation and activation, and enabled clinical-scale dose production within 2 to 3 weeks. Since then, the technology has become well established in the industry and has been used in over 200 clinical trials to provide critically needed treatment for patients